Advocate Group’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09M Sell
112,683
-5,912
-5% -$413K 1.07% 42
2026
Q1
$8.95M Sell
118,595
-4,013
-3% -$286K 1.4% 32
2025
Q4
$7.57M Sell
122,608
-6,230
-5% -$367K 1.22% 35
2025
Q3
$7.56M Sell
128,838
-542
-0.4% -$31.6K 1.24% 34
2025
Q2
$7.54M Sell
129,380
-3,320
-3% -$188K 1.35% 29
2025
Q1
$6.59M Sell
132,700
-55
-0% -$2.81K 1.2% 38
2024
Q4
$5.94M Sell
132,755
-1,587
-1% -$75.3K 1.12% 40
2024
Q3
$6.46M Buy
134,342
+2,275
+2% +$110K 1.17% 39
2024
Q2
$6.72M Buy
132,067
+3,166
+2% +$173K 1.35% 31
2024
Q1
$7M Buy
128,901
+21,386
+20% +$1.11M 1.39% 29
2023
Q4
$6.06M Buy
107,515
+3,545
+3% +$200K 1.3% 30
2023
Q3
$6.42M Buy
103,970
+11,549
+12% +$731K 1.49% 19
2023
Q2
$5.46M Buy
92,421
+15,555
+20% +$990K 1.2% 34
2023
Q1
$5.68M Sell
76,866
-2,603
-3% -$201K 1.24% 34
2022
Q4
$5.8M Buy
79,469
+830
+1% +$65.6K 1.25% 32
2022
Q3
$6.56M Sell
78,639
-1,464
-2% -$126K 1.62% 21
2022
Q2
$6.38M Buy
+80,103
New +$7.78M 1.49% 24

Other funds holding NTR

Advocate Group's NTR Position: Q2 2026 in Review

Advocate Group reduced its Nutrien (NTR) stake by 5% in Q2 2026, selling an estimated $413K and leaving 112,683 shares worth $7.09M. The position accounts for 1.07% of the portfolio, ranked #42.

Advocate Group first reported a position in NTR in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.95M in Q1 2026. 154 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Advocate Group held 112,683 shares of Nutrien worth $7.09M as of Q2 2026.
  • Advocate Group sold 5,912 Nutrien shares in Q2 2026, an estimated $413K.
  • Nutrien made up 1.07% of Advocate Group's portfolio in Q2 2026, its #42 holding.
  • Advocate Group first reported a position in Nutrien in Q2 2022 and has held it in 17 quarters since.
  • Advocate Group's Nutrien position peaked at $8.95M in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.